Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

8.0K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.0K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

25
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
25
Gene Therapy00:59

Gene Therapy

25.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.8K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

SBK2 Links Cardiac Stress Signaling to Mitochondrial Proteostasis.

Circulation research·2026
Same author

Selective expansion of cardiac macrophage subtypes distinguishes their functional roles in disease and homeostasis.

The Journal of clinical investigation·2026
Same author

Measuring Calcium Efflux in Isolated Primary Mitochondria.

Current protocols·2026
Same author

Heart-Specific and Conditional Deletion of the <i>Immt</i> Gene Reveals Its Role in Regulating Mitochondrial Structure and Total Heart Metabolism.

Cells·2026
Same author

Immune checkpoint inhibitor-induced myocarditis is dependent on CD8 T cell-derived TNF and TNFR2 signaling.

The Journal of experimental medicine·2026
Same author

AI-based Predictive Signaling Pathway Profiling in Cardiac Fibrosis Suggests a Novel Combinatorial Treatment Strategy.

bioRxiv : the preprint server for biology·2026

相关实验视频

Updated: Sep 9, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.2K

德沃夫基因疗法改善心脏处理和线粒体功能

Omar Brito-Estrada1,2,3, Yasuhide Kuwabara1,4, Aaron M Gibson1

  • 1Division of Molecular Cardiovascular Biology, The Heart Institute, Cincinnati Children's Hospital Medical Center, OH. (O.B.-E., Y.K., A.M.G., K.R.H., M.L.K., J.P.V., N.S.B., J.H., J.D.M., C.A.M.).

Circulation research
|September 5, 2025
PubMed
概括

过度表达心脏微蛋白DWORF可以改善处理和线粒体功能,从而防止心力衰竭的进展. 这种基因疗法有望通过增强心脏能量和减少病态重塑来治疗心力衰竭.

关键词:
没有心肌病,扩大基因治疗线粒体肌细胞,心脏

更多相关视频

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.5K
Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
07:32

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

1.5K

相关实验视频

Last Updated: Sep 9, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

8.2K
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.5K
Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
07:32

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

1.5K

科学领域:

  • 心脏病学
  • 分子生物学
  • 线粒体生理学

背景情况:

  • (Ca2+) 失调是心力衰竭的核心原因,导致心脏功能受损和心脏重塑.
  • 在心力衰竭中,肉质网膜Ca2+ ATPase异形2a (SERCA2a) 的活性下降.
  • 心脏微蛋白DWORF增强了SERCA2a活性,改善了心肌细胞的循环.

研究的目的:

  • 调查DWORF过度表达是否改善SR Ca2+处理和线粒体Ca2+信号传递.
  • 确定DWORF是否可以防止压力过重引起的心力衰竭.
  • 评估DWORF对心脏功能,新陈代谢和重塑的影响.

主要方法:

  • 在转基因小鼠和腺相关病毒 (AAV) 载体中,DWORF过度表达.
  • 在小鼠中通过横向大动脉收缩 (TAC) 诱导心力衰竭.
  • 对心脏功能,线粒体呼吸,Ca2+吸收和病态重塑进行评估.

主要成果:

  • 过度表达DWORF增强了线粒体呼吸和Ca2+吸收动力学.
  • 观察到活跃的酸盐脱酶 (PDH) 和线粒体Ca2+单载体的水平升高.
  • 通过AAV介导的DWORF输送可以防止TAC诱导的心脏功能障碍和减弱的重塑.
  • 既有预防方法,也有既有心力衰竭治疗模式,均可获得益处.

结论:

  • 增强SR Ca2+动力学和线粒体能量学.
  • 过度表达会减轻病态重塑和心力衰竭的进展.
  • 在心力衰竭治疗中,DWORF是一个有前途的治疗点.